Top-Rated Weight Loss Injections Near Me: What the Trial Data Shows

What the trials established about each injection's effectiveness

SURMOUNT-1, the pivotal phase-3 trial for tirzepatide, enrolled 2,539 adults with obesity and reported average body-weight reductions of around 20–21% over 72 weeks at the highest dose, figures that shifted clinical expectations considerably. The trial was published in the New England Journal of Medicine and formed the basis for the NICE recommendation that followed. In the head-to-head SURMOUNT-5 trial (72 weeks, adults with obesity and no diabetes), tirzepatide produced greater average weight loss than semaglutide 2.4mg, the most direct comparison the evidence currently offers.

Semaglutide at its 2.4mg weekly dose (Wegovy) produced around 15% average weight reduction over 68 weeks in STEP 1, and a newly approved 7.2mg dose has reported approximately 20.7% average loss over 72 weeks in further studies. These are population averages from controlled trials; individual results vary, and both are described by the NHS as significant advances on previous options. The NHS medicines page for tirzepatide and its semaglutide equivalent set out the expected benefits and risks in plain language.

One misconception worth setting aside: trial participants were not, as some assume, simply eating very little and crediting the injection. Appetite reduction is a pharmacological effect of both medicines (GLP-1 receptor activity slows gastric emptying and signals fullness) not a side-effect of willpower. That distinction matters when people ask whether results are 'real', and if you want a broader view of how different options compare, our guide to the top rated weight loss injections breaks down what the evidence shows for each. They are, and they are measurable.

How UK licensing and prescribing eligibility actually work for these injections

Both medicines are licensed for adults whose BMI is 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone does not guarantee approval, a prescriber reviews the full clinical picture, including other medicines you take and relevant medical history.

Tirzepatide carries a NICE recommendation (TA1026, updated September 2025) for adults with a BMI of 35 or above plus at least one weight-related comorbidity, which sets the bar for NHS access. Private eligibility, per the licensed criteria, is broader. If you want to understand where you might sit, our weight loss injections overview covers the licensed criteria in detail. The key point is that the prescription route (whether NHS or private) exists to protect you, not to add friction.

For context on what treatment costs privately and how that pricing is structured, the cost context page explains what a legitimate price should include and what headline figures often leave out.

What 'near me' realistically means for regulated, safe access

People searching for weight loss injections near me are usually looking for convenience and confidence: they want treatment without a long wait, and they want to know it's genuine. Both are reasonable. The practical answer in 2025–2026 is that regulated access has shifted significantly online. A GPhC-registered online pharmacy with a prescriber reviewing your consultation the same day can dispatch a genuine, UK-supply-chain pen for next-working-day delivery (tracked, in plain packaging) without you travelling anywhere.

That matters partly because of counterfeits. The MHRA has warned repeatedly about fake weight-loss pens sold online and through social media, including the seizure of approximately 20 million doses of illegally traded medicines worth around £45 million at street value in 2025. Pens sold without a prescription, via social channels or at prices far below the market, are a significant risk. Checking that any pharmacy you use appears on the GPhC pharmacy register takes about thirty seconds and is the clearest single indicator of legitimacy.

At nume, every consultation is read by a named GPhC-registered Independent Prescriber (not software) on the day you submit it. Once clinically approved, treatment is dispatched the same day for free next-working-day delivery. You can verify our pharmacy on the GPhC register using premises number 9012878. If you'd like to learn more about our clinical team and approach, the about us page covers how the service is structured and regulated.

Side effects and what to watch for once treatment starts

Both injections share a gastrointestinal side-effect profile: nausea, loose stools, constipation, indigestion and reduced appetite are the most commonly reported effects, particularly when starting or moving to a higher dose. For most people these settle within a couple of weeks. Fatigue, headache and injection-site reactions are also reported, and our overview of the top weight loss injections includes a summary of how these profiles differ between options. The NHS tirzepatide page lists the full range in accessible terms.

A point worth taking seriously: in January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but potentially serious effect of GLP-1 medicines. Severe stomach pain (especially if it reaches through to your back and does not ease) warrants urgent medical attention, not a wait to see how it develops. Gallbladder symptoms, signs of dehydration from persistent vomiting, and any allergic reaction are also reasons to seek prompt help. Patients can report suspected side effects directly through the MHRA Yellow Card scheme.

Under-18s are not licensed for either medicine. Pregnancy, breastfeeding and trying to conceive are all contraindications; specific contraception guidance applies for women using oral contraceptives alongside tirzepatide, so this is a conversation to have with your prescriber at the outset. Patients based in the Isle of Man can find guidance relevant to their location on our weight loss injections Isle of Man page, which covers access and prescribing arrangements there. Our FAQs address a number of the practical questions that come up most often once treatment starts.

If you're ready to find out whether you're clinically suitable, check your eligibility with a free consultation, reviewed the same day by one of our prescribers.